Skip to main content
Clinical Trials/NL-OMON39439
NL-OMON39439RecruitingPhase 3

Value of multiparametric MR and MRI-guided biopsies of the prostate in men with an elevated PSA - Value of MRI in diagnosing prostate cancer

niversitair Medisch Centrum Sint Radboud0 sites620 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
620

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Men, 50-75 years, PSA > 3 ng/ml

Exclusion Criteria

  • Use of 5-alfareductase inhibitors
  • Proven prostate cancer

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Similar Trials